Home NDC 0944-2884 GLASSIA
Product NDC 0944-2884
11-digit product format 009442884
Labeler code 0944
Product ID 0944-2884_312a9f40-d4bd-4cc2-810a-2df7d7baead8
Type PLASMA DERIVATIVE
Nonproprietary name ALPHA.1-PROTEINASE INHIBITOR HUMAN
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Takeda Pharmaceuticals America, Inc.
Application BLA125325
Marketing category BLA
Marketing start 2010-07-01
Substance .ALPHA.1-PROTEINASE INHIBITOR HUMAN
Active strength 1 g/50mL
Pharmacologic classes Human alpha-1 Proteinase Inhibitor [EPC], Trypsin Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base GLASSIA
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength .ALPHA.1-PROTEINASE INHIBITOR HUMAN 1 g/50mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination F43I396OIS Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1013867 Internal RxNorm lookup 1661208 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0944-2884-01 GLASSIA 1 in 1 CARTON INJECTION, SOLUTION 1 31 0944-2884-02 GLASSIA 50 mL in 1 VIAL, GLASS INJECTION, SOLUTION 50 31 0944-2884-03 GLASSIA 1 in 1 CARTON INJECTION, SOLUTION 1 31 0944-2884-04 GLASSIA 200 mL in 1 VIAL, GLASS INJECTION, SOLUTION 200 31 0944-2884-05 GLASSIA 1 in 1 CARTON INJECTION, SOLUTION 1 31 0944-2884-06 GLASSIA 250 mL in 1 VIAL, GLASS INJECTION, SOLUTION 250 31
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0944-2884 GLASSIA (ALPHA.1-PROTEINASE INHIBITOR HUMAN) INJECTION, SOLUTION [TAKEDA PHARMACEUTICALS AMERICA, INC.] 30 Current NDC, Legacy NDC, 6 package rows 20250316_83473cbb-48e4-42a2-81b6-4c851423da7b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join GLASSIA ALPHA.1-PROTEINASE INHIBITOR HUMAN Takeda Pharmaceuticals America, Inc. 83473cbb-48e4-42a2-81b6-4c851423da7b 2025-12-02 Warnings, Adverse reactions Exact identifier application number: BLA125325 ndc (product): 0944-2884
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125325 Glassia Alpha-1-Proteinase Inhibitor (Human) 351(a) Rx 2026-10-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0944-2884-01 00944288401 1 VIAL, GLASS in 1 CARTON (0944-2884-01) / 50 mL in 1 VIAL, GLASS (0944-2884-02) 2010-07-01 0000-00-00 No No Current 0944-2884-02 00944288402 50 mL in 1 VIAL, GLASS 50 ml Historical 0944-2884-03 00944288403 1 VIAL, GLASS in 1 CARTON (0944-2884-03) / 200 mL in 1 VIAL, GLASS (0944-2884-04) 2010-07-01 No No Current 0944-2884-04 00944288404 200 mL in 1 VIAL, GLASS 200 ml Historical 0944-2884-05 00944288405 1 VIAL, GLASS in 1 CARTON (0944-2884-05) / 250 mL in 1 VIAL, GLASS (0944-2884-06) 2010-07-01 No No Current 0944-2884-06 00944288406 250 mL in 1 VIAL, GLASS 250 ml Historical